home / stock / rvph / rvph news

RVPH News and Press, Reviva Pharmaceuticals Holdings Inc. From 11/12/25

Stock Information
Company Name: Reviva Pharmaceuticals Holdings Inc.
Stock Symbol: RVPH
Market: NASDAQ
Website: revivapharma.com
Menu
RVPH RVPH Quote RVPH Short RVPH News RVPH Articles RVPH Message Board
Get RVPH Alerts

News, Short Squeeze, Breakout and More Instantly...
RVPH - Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025

CUPERTINO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syst...
RVPH - Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis

- Patent covers brilaroxazine use for treating Pulmonary Fibrosis -Similar patents have also been granted in key markets around the world including the United States, China, and Japan -Brilaroxazine has a novel mechanism of action for treating the underlying disruption in serotoni...

RVPH - Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference

CUPERTINO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syst...

RVPH - Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

CUPERTINO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syst...
RVPH - Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syst...

RVPH - Morning Market Snapshot: Small?Caps and Bio Tools Jockey for Attention

2025-10-07 10:32:59 ET DENVER, Colo., Oct 07, 2025 ( 247marketnews.com )- Small-caps are seeing early‐day action as a mix of cash raises, pipeline expansion, and new tech breakthroughs drive speculation today. NUBURU (NYSE:BURU) is in focus after completing a $12 millio...

RVPH - Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference

CUPERTINO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syst...
RVPH - Reviva to Participate in the Lytham Partners Fall 2025 Investor Conference

CUPERTINO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous sys...

RVPH - US Companies Moving the Markets, Evening edition
Fri, Sep 19, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Chijet Motor Company Inc. (CJET) rose 187.2% to $0.2909 on volume of 1,670,059,982 shares Youxin Technology Ltd (YAAS) rose 15.2% to $0.087 on volume of 640,038,667 shares Adaptimmune Therapeutics plc (ADAP) fell 9.8% to $0.1444 on volu...

RVPH - US Companies Moving the Markets, Morning edition
Fri, Sep 19, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Chijet Motor Company Inc. (CJET) rose 58.8% to $0.1609 on volume of 442,667,848 shares Adaptimmune Therapeutics plc (ADAP) rose 22.4% to $0.1959 on volume of 205,010,673 shares AGM Group Holdings Inc. (AGMH) rose 180.7% to $6.26 on volu...
Previous 10 Next 10